|
|
MER-101 is a novel, first in class mRNA immunotherapy based on the protein USP6. MER-101 upregulates multiple immunostimulatory pathways simultanously leading to a potent immune response against the tumor. Initially MER- Visit Merlin Biotech MER-101 Oncology therapeutic program (https://www.merlinbiotech.com/pipeline/program-mer-101/)
|
Top Keywords: mer, 101, mer 101, merlin, biotech, usp6, mrna, pathways, merlin biotech, protein, immune, therapeutic, first in class, first in, in class, pipeline, oncology, novel, program, class, on the protein, is a novel, leading to a, immune response, the protein, the tumor, a potent, a novel, immunotherapy, tumor, potent, initially, a, leading to, against the, multiple, Theres a total of 153 keywords.
Inbound and Outbound LinksThere is a total of 1 inbound link to this page. There is currently no known outbound links. |
Statistics
We first found this page on 2023-05-28 22:04:01 +0000. It was last re-indexed on 2024-10-20 00:52:54 +0000 and with a fetch interval of 90 days it will be fetched again in 9 days on 2025-01-17 or soon thereafter.
Last fetch returned code 200, OK, the current page state is ACTIVE.
Traffic Data for www.merlinbiotech.com
Traffic data is only available for sites with a CashRank of $15 or better, an Alexa rank better than 100,000 or PageRank of 2 or more.If you are the owner of /www.merlinbiotech.com and you want to remove this page from the search results, just use robots.txt
Similar Sites
Merlin Biotech Pipeline
Merlin is developing novel approaches to diseases where there are few effective therapies. Our lead asset, MER-101 is a first-in-class immuno-oncology therapy being developed solely by Merlin for adult solid cancers and
https://www.merlinbiotech.com/pipeline/
- Details - Similar
Merlin Biotech Merlin Biotech Reveals Novel Cancer Immunotherapy a
Doylestown, Pennsylvania – January 20, 2023 Merlin Biotech, a spinout from the Baruch S. Blumberg Institute, presented its first asset last week at the 15th Annual Biotech Showcase, an investor conference focused on driv
https://www.merlinbiotech.com/news/merlin-biotech-reveals-novel-cancer-immunotherapy-at-biotech-showcase-2023/
- Details - Similar
Merlin Biotech
Merlin Biotech is developing novel treatments using the clinically-proven mRNA platform. Our company is founded on the vision of bringing new therapies to diseases where few exist.
https://www.merlinbiotech.com/
- Details - Similar
Merlin Biotech MERLIN Biotech CEO to present at BioFuture Nov. 8
Doylestown, Pa., Nov. 4, 2022 – MERLIN Biotech CEO Randall N. Hyer, MD, PhD, MPH, will present an overview of his new company’s highly promising technology and its strategic plan on Nov. 8 at 12:10 p.m. EST at BioFuture,
https://www.merlinbiotech.com/news/merlin-biotech-ceo-to-present-at-biofuture-nov-8/
- Details - Similar
More sites similar to Merlin Biotech MER-101 Oncology therapeutic program...
Find Another Website
Sponsored Results
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less